CSIMarket
 
Travere Therapeutics Inc   (TVTX)
Other Ticker:  
 
 

Travere Therapeutics Inc Income Statement Annual

TVTX


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Annual GAAP In millions $)

(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Revenue From Contract With Customer Excluding Assessed Tax 145.24 212.02 227.49 175.34 164.25
Revenue From Contract With Customer Excluding Assessed Tax - - - - -
Total Revenue 145.24 212.02 227.49 175.34 164.25
Cost of Goods and Services Sold 11.45 7.59 6.78 5.23 5.53
Gross Profit 133.79 204.43 220.71 170.10 158.72
Selling, Administration, Marketing 265.54 220.21 149.88 128.95 103.65
Depriciation & Amortization - - - - -
Research and Development Expense (Excluding Acquired in Process Cost) 244.99 235.78 210.33 140.96 123.76
Restructuring Charges 11.39 - - 40.50 -0.24
Other operatinig exp. /-income - 15.01 - - -
Unusual Expense /-Income - - - - -
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability - - - - 11.59
Changein Fair Value of Contingent Consideration - - 22.26 15.05 -
Write Off Of Contingent Consideration - - - -18.00 -
Total operating costs including COS 533.38 478.58 389.26 312.70 244.29
Operating income/-loss -388.14 -266.57 -161.77 -137.36 -80.04
Other Deductions / - Income
Interest expense 11.33 11.28 20.14 18.83 9.81
Interest income - - - - -
Net interest expense/-income -11.33 11.28 20.14 18.83 5.50
Extinguishment of Debt - 7.58 - - 17.04
Investment Income, Interest - - - - -
Foreign Currency Transaction Gain (Loss), Realized - - - - -0.04
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -23.36 -7.25 -2.22 -9.74 -0.68
Total costs & expenses 521.35 490.19 407.17 321.79 266.11
Income /-loss before income taxes -376.11 -278.17 -179.68 -146.45 -101.87
Income taxes expenses/-benefit 0.22 0.31 0.41 -0.02 0.81
Income after income taxes -376.33 -278.48 -180.09 -146.43 -102.68
Net income/-loss of other equity - 0.00 0.00 0.00 0.00
Income/-loss from cont. Ops. -376.33 -278.48 -180.09 -146.43 -102.68
Accounting change - - - - -
Discontinued operations 264.93 - - - -
Extraordinary items - - - - -
Net Income/-loss -111.40 -278.48 -180.09 -146.43 -102.68
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder -111.40 -278.48 -180.09 -146.43 -102.68
EBIT -387.44 -266.89 -159.54 -127.62 -96.37
EBITD -348.91 -233.82 -132.92 -107.21 -77.70
EBITDA -347.20 -232.19 -121.68 -97.31 -73.92


Per Share (GAAP Annual, in $) (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Basic EPS (excl. extra items) -5.07 -4.37 -3.01 -3.46 -2.54
   Extraordinary items 3.57 0.00 0.00 0.00 0.00
Basic Net EPS -1.50 -4.37 -3.01 -3.46 -2.54
Basic shares outstanding (Mill. of Units) 74.27 63.76 59.83 42.34 40.43
   EPS other shares - - - - -
Diluted Net EPS -1.50 -4.37 -3.01 -3.46 -2.54
Diluted average shares (Mill. of Units) 74.27 63.76 59.83 42.34 40.43
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com